Get Access Now: Car t Cell Therapy for Aggressive Non-Hodgkin Lymphoma

November 17, 2017 | City of Hope

City of Hope is now offering the first-ever FDA-approved CAR T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.

Continue Reading

City of Hope to provide first FDA-approved CAR T cell therapy for some patients with ALL

April 13, 2018 | City of Hope

City of Hope recently announced that it is a certified treatment center to administer tisagenlecleucel CAR T cell therapy – the first CAR T cell therapy approved by the U.S. Food and Drug Administration – to patients.

City of Hope Expands Radiation Oncology Offering Across Southern California

April 2, 2018 | City of Hope

City of Hope today announced it is adding nine radiation oncology sites to City of Hope Medical Foundation through a joint venture with Vantage Oncology

New CAR T Cell Therapy Breakthroughs Announced at ASH

December 14, 2017 | Letisia Marquez

New blood cancer breakthroughs – including several involving CAR T cell therapy – were announced by City of Hope physicians at the American Society of Hematology (ASH) annual meeting in Atlanta.

Geriatric assessment guides treatment strategy for older adults with cancer

December 1, 2017 | City of Hope

Researchers developed a self-administered geriatric assessment to identify areas of vulnerability and guide interventions for older adults with cancer.

Renowned Cancer Researcher Named President of City of Hope National Medical Center and Physician-in-Chief of City of Hope

November 28, 2017 | City of Hope

Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.

Get Access Now: Car t Cell Therapy for Aggressive Non-Hodgkin Lymphoma

November 17, 2017 | City of Hope

City of Hope is now offering the first-ever FDA-approved CAR T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.

Immunologist Bart Roep, Ph.D., Thinks T1D Cure Is in Sight

June 27, 2017 | Samantha Bonar

Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes.

City of Hope Presents Groundbreaking Research at ASCO 2017

June 2, 2017 | Letisia Marquez

City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.

Liquid Biopsy Pioneers, Changing the Diagnostic Paradigm

May 24, 2017 | City of Hope

Genetically targeted therapies are becoming standard in cancer therapy and clinicians at City of Hope are pioneering liquid biopsy, a new noninvasive way of obtaining samples to make strategic therapeutic decisions with less discomfort, and less risk to patients.

New Cysview Technology Aids in the Treatment of Bladder Cancer

May 18, 2017 | Katie Neith

Using a simple but unique approach to image bladder cancer cells called Cysview, physicians at City of Hope are getting a better look at tumors and other abnormalities within the organ.

Load More